With the early detection of cancer and improvement in cancer therapy, the number of cancer survivors is rapidly increasing. This number is expected to reach 2 million by the end of 2019. Cancer survivors struggle with not only cancer-related health problems but also diverse acute and chronic diseases. These health issues make cancer survivorship more complex, and proper care coordination is necessary. This study aimed to summarize the definition of cancer experience and management of cancer survivors, specifically focused on gastric, colorectal, lung, breast, thyroid, prostate, and cervical cancers. Furthermore, it aimed to discuss the role of primary care in cancer survivorship and survivorship care models and the National Policy for Cancer Survivors and Future Challenges.
INTRODUCTION
It has become more common nowadays to find cancer survivors in primary care settings. This is because the number of cancer survivors is rapidly increasing due to an increase in the rate of early cancer detection and improvement in cancer treatment. In 2016, >1.7 million Korean individuals were living with cancer, which accounts for 3.4% of the total population. 1) Furthermore, in older individuals, cancer survivors accounted for 11.0% of the total population aged ≥65 years, implying that not only cancer-related health problems but also age-related chronic diseases need to be addressed in this population. Diverse healthcare needs, including primary cancer surveillance, management of acute and chronic problems, and disease prevention services, make cancer survivorship more complex. Proper care coordination is an essential part of survivorship care. Thus, cancer survivorship has deeply entered the primary care area and become unavoidable for primary care physicians. Therefore, we aimed to review the definition of cancer experience, management of cancer survivors, role of primary care in the management of cancer survivors, survivorship care models, and the National Policy for Cancer Survivor and Future Challenges.
DEFINITION OF CANCER SURVIVORS AND SURVIVORSHIP
A cancer survivor refers to an individual who is diagnosed with cancer, regardless of the course of the disease. Cancer survivorship includes not only cancer survivors themselves but also their family members and caregivers. Although the health and psychosocial problems that cancer survivors experience as they go through their survivorship trajectory are different from those of individuals without cancer, survivors have somewhat similar experience to a certain extent along their journey. Mullan 2) described that this unique features of survivorship were similar to the seasons of the year and identified the following three seasons of survivorship: (1) acute survivorship, (2) extended survivorship, and (3) permanent survivorship. The acute survivorship phase is dominated by cancer treatments; optimal care for treatment-related adverse effects, such as pain, fatigue, and emotional distress, is important in this stage. 3, 4) The extended survivorship phase is referred to as the transitioning period. This period begins after the primary treatment for cancer ends, and support care for patients having physical, psychological, and social readjustments is the mainstream of survivorship. In the permanent survivorship phase, although patients can sense that the likelihood of cancer recurrence is sufficiently low, survivors often experience difficulties in obtaining employment and health insurance. In this phase, survivors are at risk of developing secondary primary cancer and experience the late effects of cancer treatment.
In Korea, a wide range of terms such as cancer survivors, cancer overcomer, and cured cancer patients have been used to indicate cancer survivor, but no consensus has been reached with respect to the terminology. Although the term "cancer survivors" had been widely used in the previous years, an alternative term (cancer experiencer) has recently gained popularity as it does not have a negative connotation.
EPIDEMIOLOGY AND ECONOMIC BURDEN OF CANCER SURVIVORS
As the number of cancer survivors reached a million in 2014, the number of cancer survivors has continuously increased due to the early detection of cancer, improvement in cancer treatment outcomes, and preventive health behaviors among cancer survivors. 5) Based on the cancer statistics published by the Korea Central Cancer Registry in 2016, >1.7 million individuals were living with cancer, which accounts for 3.4% of the entire Korean population. 1) In 2016, 230,000 individuals were newly diagnosed with cancer. Of these, 78,000 died, and 152,000 survived. Consequently, the number of cancer survivors is predicted to exceed 2 million in Korea by the end of 2019 with this incremental trend in cancer prevalence.
The economic burden caused by cancer survivors has gradually increased, with an annual increasing rate of 8.9% from 2000 to 2010. 6) While approximately 11 billion US dollars was incurred for cancer diagnosis and treatment in 2000, the amount increased to 20 billion US dollars in 2010. Based on the Korean National Health Insurance claims data, the medical expenses for cancer survivors rapidly increased in the year of cancer diagnosis and then was 2-3 times higher in the following years. 7) Cancer-related financial burden is more prevalent in patients with comorbidities. The economic burden associated with morbidity was estimated as 2.7 billion US dollars, 8) and the proportion of morbidity-related cost incurred in Korea (23%) was much higher than that in the United States (8%). This finding suggests the lack of comprehensive rehabilitation programs that can help cancer survivors to return to work and decrease social burden associated with cancer management.
MANAGEMENT OF CANCER SURVIVORS
Cancer survivors encounter a number of physical and psychosocial issues during the cancer survivorship journey. Although most patients with cancer and oncologists focus on the surveillance of primary cancer, optimal screening strategies for secondary primary cancer are also important. Although the screening rate for secondary primary cancer among cancer survivors was higher than that among the general population (gastric cancer, 37.1% versus 31.3%; breast cancer, 50% versus 30.9%; cervical cancer, 43.1% versus 36.4%; colorectal cancer, 28.0% versus 21.4%), the screening rates in Korea remained suboptimal. 9) This finding implies that more holistic approaches should be employed to deliver appropriate cancer screening for survivors.
Once cancer is diagnosed, patients' and healthcare providers' attention is shifted away from non-cancer-related medical problems. However, comorbidity, the coexistence of multiple diseases in an individual, is another issue encountered by this population because it increases the mortality rate among cancer survivors. 10) Because comorbidity can occur as a result of cancer treatment or as a late side effect of cancer treatment, such as surgery, radiation therapy, chemotherapy, and hormonal therapy, cancer survivors show higher comorbidity rates than the general population. 11) Despite the higher comorbidity rate among cancer survivors, the comprehensive management of comorbidities, including regular follow-up for diabetes, necessary heart failure care, and preventive services, has not been conducted, 12) which puts this vulnerable population at risk of premature mortality from chronic comorbid conditions. Cancer survivors who received care from both oncologists and primary care physicians were more likely to receive appropriate care for the comorbid conditions, 12) suggesting that diseasespecific, narrow subspecialty for cancer management may limit comprehensive care.
Smoking cessation occupy a large part of survivorship because smoking decreases the effectiveness of cancer treatments, increases the risk of treatment-related complications, and decreases survival time due to cancer progression and recurrence. 13) After 2 years of cancer diagnosis, the smoking rate of male cancer survivors dropped from 34.6% to 15.9%; however, a slight increase in the smoking rate was reported 5 years after cancer diagnosis (16.3%). 14) Furthermore, although the current smoking rate of male cancer survivors was lower than that of individuals without cancer (7.8% versus 26.4%), a significant proportion of cancer survivors (53.4%) continued to smoke even after the diagnosis of cancer. 15) With regard to alcohol cessation, the rate of male survivors who consumed high amounts of alcohol decreased from 11.4% to 5.6% 2 years after cancer diagnosis and then slightly increased to 6.6% 5 years after the diagnosis. 14) Therefore, effective smoking and alcohol cessation programs incorporated into routine cancer treatment processes are necessary to address the issue of tobacco exposure and alcohol consumption especially among male cancer survivors.
Regular physical activity has been demonstrated to improve physical functioning, enhance emotional wellness, reduce fatigue, and positively affect survival outcomes. 16) The prevalence of physical inactivity was 45.9% in men and 57.9% in women before cancer diagnosis; however, this rate remarkably decreased 5 years after cancer diagnosis, showing that only 1.1% of cancer survivors were physically inactive in both sexes. 14) Pre-exercise assessment and exercise capacity and functional test are recommended for some cancer survivors, especially patients who received chemohormonal treatments with cardiotoxic effects and those who developed chemotherapy-induced neuropathy.
Thus, an individualized exercise plan is necessary considering survivors' cardiopulmonary function, comorbidities, and treatment modalities that they received. 17) While nutritional issues highly vary depending on the cancer type, stage, and treatment, generally, a diet high in vegetables, fruits, and whole grains is recommended for cancer survivors. During acute treatment, anorexia, nausea, vomiting, and changes in smell and taste are common; hence, the goal of nutritional support is to prevent malnutrition and maintain lean body weight. Individualized nutritional counseling can help survivors improve their dietary intake and prevent the occurrence of some toxicities associated with cancer treatment. 18) In the recovery stage, maintaining a healthy body weight is vital for survivorship care because obesity increases the risk of recurrence of breast and other cancers. 19, 20) However, it remains unclear whether intentional weight reduction has a positive effect on the prognosis of cancer despite the limited number of evidence showing improved prognosis among survivors who lost weight with nutritional management. 21) The following is a description of surveillance for recurrence, late complications, comorbidities, and secondary cancer sites for stomach, colon, thyroid, breast, prostate, cervical, and lung cancer, with the highest 5-year survival and prevalence rates. Although various guidelines and research results have been reported, the guidelines published in Korea have been prioritized.
Gastric Cancer
As of 2016, the most common type of cancer affecting men and women was stomach cancer, and the relative 5-year survival rate (2012-2016) was 76.7% for men, 73.8% for women, and 75.8% for both sexes. 1) Endoscopy is recommended at least annually for recurrence surveillance in patients who have undergone endoscopic treatment for early gastric cancer. 22) For patients who underwent gastrectomy, there is no established guideline for the specific screening method and follow-up interval. Although follow-up is common in gastric cancer care, there is no evidence to support that it has any survival benefit. 23) However, experts recommend that patients with early gastric cancer should be examined for at least 5 years and after 5 years and should undergo endoscopy once a year. 24, 25) Gastrectomy will be performed, except for some types of early gastric cancers, which are indications for endoscopic resection. Postoperative complications that may develop include dumping syndrome, gastric acid and bile reflux, delayed gastric emptying, and diarrhea. To prevent the development of dumping syndrome, patients should consume smaller meals more frequently and increase the intake of proteins instead of carbohydrates. To prevent gastric acid and bile reflux, overeating and lying down after meals should be avoided, and dinner should be served 4 hours before bedtime. After gastrectomy, metabolic disorders, such as anemia, bone disease, and weight loss, usually develop. In patients who underwent total gastrectomy, iron and vitamin B12 deficiencies often cause anemia. Therefore, it is necessary to prescribe iron supplementation and cyanocobalamin intramuscular injection. Moreover, according to the results of bone mass density (dual energy X-ray absorptiometry), calcium (calcium citrate preparation) and vitamin D supplements should be administered in cases of osteopenia, and performance of weightbearing exercises is recommended. 25, 26) The relative incidence risk for secondary cancer in gastric cancer varies from study to study. According to the Osaka Cancer Registry Data study in Osaka, Japan, which has similar epidemiological characteristics to those of Korea, the standardized incidence ratio for secondary cancer after colon cancer was 1.86 for thyroid cancer, 1.68 for esophageal cancer, and 1.63 for breast cancer in women. 27) 
Colorectal Cancer
In 2016, colorectal cancer was the second most common cancer in Korea after stomach cancer. The 5-year relative survival rate (2012-2016) was 77.8% for men, 73.4% for women, and 76.0% for both sexes. 1) Approximately 80% of colorectal cancers recur within 2-2. (Table 1) . [26] [27] [28] [29] [30] [31] [32] The interval between colonoscopies is still unclear, but experts recommend that it should be conducted within 1 year after colon cancer surgery and every 3-5 years thereafter. 33, 34) The goal of colorectal cancer treatment is radical resection. Long-term side effects of surgery include chronic diarrhea or incontinence, urination, and sexual dysfunction.
Additionally, long-term survivor studies, including those on colorectal cancer, reported that patients with cancer had a higher risk of developing cardiovascular diseases related to obesity, hypertension, diabetes, and physical inactivity than the general population. 35) Therefore, primary care physicians who are managing patients with colorectal cancer should provide active counseling to help these patients prevent the development of cardiovascular diseases. Moreover, patients with colorectal cancer are 1.68 times more likely to develop dementia than the general population, 36) while those who underwent chemotherapy and aged >70 years are more vulnerable to cognitive decline. 37) Secondary cancer incidence in colon cancer survivors varies from study to study, but it is known to increase the risk of thyroid, ovarian, uterine, kidney/urinary tract/bladder, and gastric cancer ( Table 1) . [26] [27] [28] [29] [30] [31] [32] 
Lung Cancer
Lung cancer was the fourth most common cancer in Korea in 2016, the second most common after gastric cancer in men, and the fifth Table 1) . [26] [27] [28] [29] [30] [31] [32] 
Breast Cancer
Breast cancer is the second most common cancer in Korean women after thyroid cancer, with a 5-year survival rate of 92.7%. 1 26) Not only does the risk of diabetes increase in breast cancer survivors, but diabetes also affects the prognosis of breast cancer, increasing the risk of breast cancer recurrence. Meanwhile, the use of metformin in patients with breast cancer with diabetes reduced the risk of breast cancer deaths, and the risk of breast can-cer in patients with diabetes who used metformin was lower than that in patients who used other medications. 43) The prevalence rate of hyperlipidemia in patients with breast cancer using aromatase inhibitor was 40%-60%. 44) Moreover, >80% of patients with breast cancer had bone loss due to treatment. 45) Secondary cancers that commonly develop among breast cancer survivors are thyroid, ovarian, uterine, esophageal, stomach, and colorectal cancers ( Table 1) . [26] [27] [28] [29] [30] [31] [32] 
Thyroid Cancer
Thyroid cancer is the third most common cancer in Korea, and the 46, 47) Secondary cancers that developed in high-risk thyroid cancer survivors were breast cancer in women and prostate cancer in men (Table 1) . [26] [27] [28] [29] [30] [31] [32] 
Prostate Cancer

Cervical Cancer
The incidence of cervical cancer has been on a steady decline since 1999, but this is considered to be due to the early diagnosis and treatment of cervical cancer rather than just an absolute decrease. It has a https://doi.org/10.4082/kjfm.19.0108 
NATIONAL POLICY FOR CANCER SURVIVOR AND FUTURE CHALLENGES
The cancer policy branch of the National Cancer Control Institute de- 
